LiveWire Ergogenics Begins Process to Return to Full SEC Reporting Status and Uplist to OTCQB

UNITED STATES


Anaheim, CA, April 05, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV) announced today that it has retained AMC Auditing of Las Vegas, Nevada to audit the Company’s operations and financials to comply with SEC Reporting requirements for small SEC-reporting companies. The company will also provide the OTC Markets Group with the materials required to be uplisted to OTCQB. Until this process has been completed, the Company will continue to file its unaudited financials as required by OTC Markets.

Retaining an auditor, becoming an SEC-filing company and being listed on OTCQB are all important to the long-term plans of LiveWire Ergogenics, which focuses on special purpose real estate acquisitions and asset management, research partnerships, cannabis product development and certification via the Company’s 7X Pure Cannabis Compliance and Dosage Verification System, and the licensing and management of turnkey production facilities for cannabis-based products and services.

Bill Hodson, CEO of LiveWire, stated, “We are delighted that we are in a position to return to the status of a fully SEC-reporting company and to uplist to OTCQB. We have spent the last two years rebuilding LiveWire and establishing our company as a significant force in the legal cannabis market in California, making sure that our activities are in strict compliance with all State and local laws and regulations.”

LiveWire has secured the required permits for cannabis nursery/cultivation and distribution from the city of Coachella in California, allowing the Company to begin production soon. In preparation for the uplisting to OTCQB, the company has filed unaudited financial statements for the past two years. Returning to being a fully SEC-reporting company will result in complete operational and financial transparency.

“We hope that providing fully audited financial statements that allow us to be quoted on the OTCQB again will provide our existing shareholders and the general investment community with the confidence to continue supporting the Company,” adds Mr. Hodson. “We have already seen a significant increase in share price over the last several months and believe that this decision for complete transparency could also support new investors in their decision to acquire positions in LiveWire.”

For more information about LiveWire Ergogenics, visit LiveWireErgogenics.com, follow LiveWire Ergogenics on Twitter.com/livewireLVVV, or download the SWI Research Report from stockwatchindex.com/livewire-ergogenics/

About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is currently focused on establishing, licensing and leasing legally fully compliant cannabis production facilities and entering into research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands via the Company’s “7X Pure” Cannabis Compliance and Dosage Verification System, and development and licensing of high-quality cannabinoid-based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality products that satisfy an increasing demand in this fast-growing industry.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.


        

Contact Data